SERPINA1 and hepatocellular carcinoma: However, AAT disrupts the vascular barrier to facilitate the invasion and metastasis of tumor cells, which drives acquired AAT resistance in cancers such as hepatocellular carcinoma (HCC) (Kuczynski et al., 2016; Angara et al., 2017).